Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Scand J Clin Lab Invest ; 60(6): 491-9, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11129065

RESUMO

Hyperhomocysteinaemia has been identified as a risk factor for stroke and cerebrovascular disease in several studies. To evaluate the evidence we performed a meta-analysis. We found 21 studies searching Medline from 1966-July 1999 using the key words homocysteine, homocystine and cerebrovascular disease or stroke combined with a search of Embase, Science Citation Index and Biological Abstract. In 17 of these studies the populations were comparable. The studies were divided into two groups, cross-sectional studies and longitudinal studies where a pre-insult plasma or serum total homocysteine was used. The reports on 8 cross-sectional and 4 longitudinal studies gave data on the mean and standard deviations of plasma or serum homocysteine for both cases and controls, and these studies were included in the meta-analysis. The results of the 5 excluded studies all pointed to a positive relationship between hyperhomocysteinaemia and cerebrovascular disease. For each study, the expected fractions of the cases with total homocysteine higher than the 95-percentile for the controls were calculated, using the means and standard deviations, assuming a log-normal distribution, and the odds-ratios for disease with total homocysteine above the 95-percentile were computed. The overall weighted odds-ratio for disease with a concentration of homocysteine in plasma or serum above the 95-percentile (95% confidence interval) for the cross-sectional studies was 4.12 (2.94-5.77), for the longitudinal studies 3.74 (2.53-5.54), and for all 12 studies 3.97 (3.07-5.12). In conclusion, the results support the case for a strong relation between hyperhomocysteinaemia and cerebrovascular disease.


Assuntos
Transtornos Cerebrovasculares/sangue , Homocisteína/sangue , Estudos Transversais , Humanos , Estudos Longitudinais , Fatores de Risco
2.
Biochem J ; 302 ( Pt 3): 801-6, 1994 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-7945205

RESUMO

Dinitrogenase reductase-activating glycohydrolase (DRAG) is responsible for removing the ADP-ribose moiety from post-translationally inactivated nitrogenase of Rhodospirillum rubrum. Using DRAG purified from an overexpressing strain (UR276), further properties of this enzyme were studied, including its u.v.-visible and fluorescence spectra and its stability in air. DRAG appears to require no covalently bound inorganic cofactors for its activity or regulation. Previously, purified DRAG was found to be rapidly inactivated in air. The air-catalysed lability originated with the presence of sodium dithionite and Mn2+ throughout the purification of the enzyme. This lability can be mimicked using H2O2, which is known to oxidatively inactivate proteins containing bivalent metals. Implications for the regulation of nitrogenase are discussed with respect to the lack of sensitivity to air of the regulatory enzyme, DRAG.


Assuntos
Glicosídeo Hidrolases/isolamento & purificação , Glicosídeo Hidrolases/metabolismo , N-Glicosil Hidrolases , Fixação de Nitrogênio , Rhodospirillum rubrum/enzimologia , Eletroforese em Gel de Poliacrilamida , Estabilidade Enzimática , Glicosídeo Hidrolases/química , Peróxido de Hidrogênio/farmacologia , Oxigênio/farmacologia , Espectrometria de Fluorescência , Espectrofotometria Ultravioleta
3.
J Bacteriol ; 173(21): 6903-9, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1938894

RESUMO

Reversible ADP-ribosylation of dinitrogenase reductase forms the basis of posttranslational regulation of nitrogenase activity in Rhodospirillum rubrum. This report describes the physiological effects of mutations in the genes encoding the enzymes that add and remove the ADP-ribosyl moiety. Mutants lacking a functional draT gene had no dinitrogenase reductase ADP-ribosyltransferase (DRAT, the draT gene product) activity in vitro and were incapable of modifying dinitrogenase reductase with ADP-ribose in vivo. Mutants lacking a functional draG gene had no dinitrogenase reductase-activating glycohydrolase (DRAG, the draG gene product) activity in vitro and were unable to remove ADP-ribose from the modified dinitrogenase reductase in vivo. Strains containing polar mutations in draT had no detectable DRAG activity in vitro, suggesting likely cotranscription of draT and draG. In strains containing draT and lacking a functional draG, dinitrogenase reductase accumulated in the active form under derepressing conditions but was rapidly ADP-ribosylated in response to conditions that cause inactivation. Detection of DRAT in these cells in vitro demonstrated that DRAT is itself subject to posttranslational regulation in vivo. Mutants affected in an open reading frame immediately downstream of draTG showed regulation of dinitrogenase reductase by ADP-ribosylation, although differences in the rates of ADP-ribosylation were apparent.


Assuntos
Glicosídeo Hidrolases/genética , Mutação , N-Glicosil Hidrolases , Nitrogenase/metabolismo , Poli(ADP-Ribose) Polimerases/metabolismo , Rhodospirillum rubrum/genética , Amônia/farmacologia , Clonagem Molecular , Escuridão , Genes Bacterianos , Glicosídeo Hidrolases/metabolismo , Immunoblotting , Fenótipo , Rhodospirillum rubrum/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA